Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.

Saved in:
Bibliographic Details
Title: Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma.
Authors: Denlinger N; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Song NJ; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Zhang X; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH., Jeon H; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH., Peterson C; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Wang Y; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Reynolds K; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Bolz RM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Miao J; Department of Neuroscience, The Ohio State University, Columbus, OH., Song C; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Wu D; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Chan WK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Bezerra E; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Epperla N; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Voorhees TJ; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Brammer J; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Kittai AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Bond DA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Sawalha Y; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Sigmund A; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Reneau JC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Rubinstein MP; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Hanel W; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Christian B; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Baiocchi RA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Maddocks K; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Alinari L; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Vasu S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., de Lima M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Chung D; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH., Jaglowski S; Medical College of Wisconsin, Milwaukee, WI., Li Z; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Huang X; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Yang Y; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Source: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3140-3153.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2023012073